Lin Shui

491 total citations
15 papers, 307 citations indexed

About

Lin Shui is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Lin Shui has authored 15 papers receiving a total of 307 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 5 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Lin Shui's work include Cancer Genomics and Diagnostics (4 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Radiomics and Machine Learning in Medical Imaging (2 papers). Lin Shui is often cited by papers focused on Cancer Genomics and Diagnostics (4 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Radiomics and Machine Learning in Medical Imaging (2 papers). Lin Shui collaborates with scholars based in China, Germany and Burundi. Lin Shui's co-authors include Yi Cheng, Hong Zhu, Xi Yang, Jian Li, Qin Sun, Jian Li, Haoyu Ren, Xiaohan Zhou, Wanting Hou and Ling Gao and has published in prestigious journals such as Frontiers in Immunology, Biomedicine & Pharmacotherapy and BMC Cancer.

In The Last Decade

Lin Shui

14 papers receiving 305 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lin Shui China 8 138 135 75 72 59 15 307
Judit Pápay Hungary 12 135 1.0× 139 1.0× 26 0.3× 129 1.8× 90 1.5× 31 338
Valentina Magri Italy 11 207 1.5× 66 0.5× 56 0.7× 63 0.9× 132 2.2× 28 345
Dajia Lin China 6 80 0.6× 53 0.4× 68 0.9× 92 1.3× 43 0.7× 9 234
Shaveta Mehta United Kingdom 7 69 0.5× 150 1.1× 48 0.6× 56 0.8× 95 1.6× 20 301
Tomohiro Kikuchi Japan 10 170 1.2× 181 1.3× 59 0.8× 51 0.7× 79 1.3× 54 443
Lounes Djerroudi France 8 137 1.0× 56 0.4× 86 1.1× 45 0.6× 103 1.7× 22 287
Miki Yamaguchi Japan 13 184 1.3× 76 0.6× 53 0.7× 35 0.5× 88 1.5× 33 436
Leigh J. Hodson Australia 7 178 1.3× 79 0.6× 28 0.4× 57 0.8× 76 1.3× 9 321
Shih‐Che Shen Taiwan 9 139 1.0× 105 0.8× 28 0.4× 43 0.6× 102 1.7× 21 303
Tiening Zhang China 6 98 0.7× 168 1.2× 40 0.5× 70 1.0× 126 2.1× 10 335

Countries citing papers authored by Lin Shui

Since Specialization
Citations

This map shows the geographic impact of Lin Shui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Shui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Shui more than expected).

Fields of papers citing papers by Lin Shui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lin Shui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Shui. The network helps show where Lin Shui may publish in the future.

Co-authorship network of co-authors of Lin Shui

This figure shows the co-authorship network connecting the top 25 collaborators of Lin Shui. A scholar is included among the top collaborators of Lin Shui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lin Shui. Lin Shui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Shui, Lin, Haoyu Ren, Xi Yang, et al.. (2021). The Era of Radiogenomics in Precision Medicine: An Emerging Approach to Support Diagnosis, Treatment Decisions, and Prognostication in Oncology. Frontiers in Oncology. 10. 570465–570465. 94 indexed citations
2.
Shui, Lin, Xiaofen Li, Yang Peng, et al.. (2021). The germline/somatic DNA damage repair gene mutations modulate the therapeutic response in Chinese patients with advanced pancreatic ductal adenocarcinoma. Journal of Translational Medicine. 19(1). 301–301. 12 indexed citations
3.
Shui, Lin, Shanshan Li, Xiaoqi Xie, et al.. (2021). Relationship between cyclooxygenase-2 (COX-2) content and prognosis in nasopharyngeal carcinoma before and after radiochemotherapy.. PubMed. 25(5). 2395–2404. 4 indexed citations
4.
5.
Li, Yan, Lin Shui, Xiaodong Wang, et al.. (2020). Long-Term Results of Partial Breast Irradiation After Breast-Conserving Surgery for Early Stage Breast Cancer: A Prospective Phase II Trial in China. Frontiers in Oncology. 10. 550950–550950. 2 indexed citations
6.
Zhou, Xiaohan, Wanting Hou, Ling Gao, et al.. (2020). Synergies of Antiangiogenic Therapy and Immune Checkpoint Blockade in Renal Cell Carcinoma: From Theoretical Background to Clinical Reality. Frontiers in Oncology. 10. 1321–1321. 23 indexed citations
7.
8.
Shui, Lin, Ke Cheng, Xiaofen Li, et al.. (2020). Durable Response and Good Tolerance to the Triple Combination of Toripalimab, Gemcitabine, and Nab-Paclitaxel in a Patient With Metastatic Pancreatic Ductal Adenocarcinoma. Frontiers in Immunology. 11. 1127–1127. 11 indexed citations
9.
Shui, Lin, Xi Yang, Jian Li, et al.. (2020). Gut Microbiome as a Potential Factor for Modulating Resistance to Cancer Immunotherapy. Frontiers in Immunology. 10. 2989–2989. 96 indexed citations
10.
Peng, Yang, Lin Shui, Jian Xie, & Shengchun Liu. (2020). Development and validation of a novel 15‐CpG‐based signature for predicting prognosis in triple‐negative breast cancer. Journal of Cellular and Molecular Medicine. 24(16). 9378–9387. 7 indexed citations
11.
Wang, Hongqiang, Yan Guo, Lin Shui, et al.. (2019). HERG1 promotes esophageal squamous cell carcinoma growth and metastasis through TXNDC5 by activating the PI3K/AKT pathway. Journal of Experimental & Clinical Cancer Research. 38(1). 324–324. 31 indexed citations
12.
Guo, Fengzhu, Gaili Ji, Qiqi Li, et al.. (2019). Bacterial particles retard tumor growth as a novel vascular disrupting agent. Biomedicine & Pharmacotherapy. 122. 109757–109757. 8 indexed citations
13.
14.
Shui, Lin. (1998). Effects of ecdysterone on human umbilical vein endothelial cells injuried by tumor necrosis factor. 2 indexed citations
15.
Shui, Lin. (1997). Effect of ecdystrone on proliferation of human umbilical vein endothelial cells. Zhongguo yaolixue tongbao.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Judit Pápay Breakdown of academic impact, for papers by Valentina Magri Breakdown of academic impact, for papers by Dajia Lin Breakdown of academic impact, for papers by Shaveta Mehta Breakdown of academic impact, for papers by Tomohiro Kikuchi Breakdown of academic impact, for papers by Lounes Djerroudi Breakdown of academic impact, for papers by Miki Yamaguchi Breakdown of academic impact, for papers by Leigh J. Hodson Breakdown of academic impact, for papers by Shih‐Che Shen Breakdown of academic impact, for papers by Tiening Zhang
Rankless by CCL
2026